urban-gro cures filing delinquency but gets two new Nasdaq deficiency notices; signs $4M hospital design contract

urban-gro, Inc.

Filed delinquent quarterly reports and 10-K amendment on Feb 18-19, 2025; Nasdaq confirmed filing compliance on Feb 24.
Received Nasdaq deficiency letter on Feb 24, 2025, for bid price below $1.00 for 30 consecutive days; has 180 days to cure until Aug 25, 2025.
Also on Feb 24, received deficiency for stockholders' equity below $2.5M as of Q3 2024; must submit compliance plan by April 10, 2025.
Signed $4M lead design contract for an $80M new hospital in southeastern U.S.; majority of revenue expected in 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.